No pharmaceutical company that is straightforward and honest and would not want to manipulate data would have any problem with this.

You might wonder why we’d publish a study involving two patients.

It is beyond me why individuals who are supposed to be overseeing the safety of the public would take a chance when it’s not necessary,

the opportunity to explain why they didn’t reveal it.

I am not against the pharmaceutical companies. I love them. That’s not the issue. The issue is, in some cases, when they do these clinical trials, they control the data. They analyze the data. In...